CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 405675-405842 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T6043","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Intrathecal administration of MCP-1 (2.5 μg) evoked an increase of EB in the spinal parenchyma in naive animals, similar to that seen in animals at 3 days post-injury."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T60","span":{"begin":0,"end":167},"obj":"Sentence"}],"text":"Intrathecal administration of MCP-1 (2.5 μg) evoked an increase of EB in the spinal parenchyma in naive animals, similar to that seen in animals at 3 days post-injury."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1755","span":{"begin":84,"end":94},"obj":"Body_part"}],"attributes":[{"id":"A1755","pred":"uberon_id","subj":"T1755","obj":"http://purl.obolibrary.org/obo/UBERON_0000353"}],"text":"Intrathecal administration of MCP-1 (2.5 μg) evoked an increase of EB in the spinal parenchyma in naive animals, similar to that seen in animals at 3 days post-injury."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2608","span":{"begin":67,"end":69},"obj":"Disease"},{"id":"T46281","span":{"begin":160,"end":166},"obj":"Disease"},{"id":"T37497","span":{"begin":67,"end":69},"obj":"Disease"},{"id":"T60904","span":{"begin":160,"end":166},"obj":"Disease"}],"attributes":[{"id":"A2608","pred":"mondo_id","subj":"T2608","obj":"http://purl.obolibrary.org/obo/MONDO_0006541"},{"id":"A2609","pred":"mondo_id","subj":"T46281","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A23657","pred":"mondo_id","subj":"T37497","obj":"http://purl.obolibrary.org/obo/MONDO_0006541"},{"id":"A72458","pred":"mondo_id","subj":"T60904","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Intrathecal administration of MCP-1 (2.5 μg) evoked an increase of EB in the spinal parenchyma in naive animals, similar to that seen in animals at 3 days post-injury."}